Search

Your search keyword '"Antoniadi, Kondilia"' showing total 15 results
Start Over Author "Antoniadi, Kondilia"
15 results on '"Antoniadi, Kondilia"'

2. Survival and prognostic factors for childhood malignant liver tumors: analysis of harmonized clinical data

Author

Antoniadi, Kondilia, Baka, Margaret, Dana, Helen, Gavra, Maria, Hatzipantelis, Emmanuel, Kourti, Maria, Malama, Astero, Papaconstantinou, Evgenia, Pelagiadis, Iordanis, Polychronopoulou, Sofia, Stefanaki, Kalliopi, Steiakaki, Eftichia, Strantzia, Katerina, Akhaladze, Dmitry, Filin, Andrey, Varfolomeeva, Svetlana, Karalexi, Maria A., Servitzoglou, Marina, Moschovi, Maria, Moiseenko, Roman, Bouka, Panagiota, Ntzani, Evangelia, Kachanov, Denis, and Petridou, Eleni Th.

Published
2021
Full Text
View/download PDF

3. Maternal lifestyle characteristics and Wilms tumor risk in the offspring: A systematic review and meta-analysis

Author

Doganis, Dimitrios, Katsimpris, Andreas, Panagopoulou, Paraskevi, Bouka, Panagiota, Bouka, Evdoxia, Moschovi, Maria, Polychronopoulou, Sofia, Papakonstantinou, Evgenia, Tragiannidis, Athanasios, Katzilakis, Nick, Dana, Helen, Antoniadi, Kondilia, Stefanaki, Kalliopi, Strantzia, Katerina, Dessypris, Nick, Schüz, Joachim, and Petridou, Eleni Th.

Published
2020
Full Text
View/download PDF

4. Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017)

Author

Doganis, Dimitrios, Zborovskaya, Anna, Trojanowski, Maciej, Zagar, Tina, Bouka, Panagiota, Baka, Margaret, Moschovi, Maria, Polychronopoulou, Sofia, Papakonstantinou, Eugenia, Tragiannidis, Athanasios, Stiakaki, Eftichia, Dana, Helen, Stefanaki, Kalliopi, Strantzia, Katerina, Kochubinsky, Dmitry, Marciniak, Patrycja, Avcin, Simona, Antoniadi, Kondilia, Dessypris, Nick, and Petridou, Eleni Th.

Published
2019
Full Text
View/download PDF

8. P23 - THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP

Author

Petrikkos, Loizos, Servitzoglou, Marina, Dana, Eleni, Pelagiadis, Iordanis, Kelaidi, Charikleia, Antoniadi, Kondilia, Ioannidou, Eleni - Dikaia, Bountali, Aikaterini, Manola, Kalliopi, Stefanaki, Kalliopi, Stiakaki, Eftichia, Kosmidis, Helen, Peristeri, Ioulia, Baka, Margarita, and Polychronopoulou, Sophia

Published
2023
Full Text
View/download PDF

9. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology

Author

Antoniadi, Kondilia Iosifidis, Elias Vasileiou, Eleni and Tsipou, Charoula Lialias, Ioannis Papakonstantinou, Eugenia and Kattamis, Antonios Polychronopoulou, Sophia Roilides, Emmanuel and Tragiannidis, Athanasios

Abstract

Mucormycosis is an invasive, life-threatening fungal infection that mainly affects immunocompromised hosts. We collected data of pediatric mucormycosis cases from all 7 Greek Hematology-Oncology Departments for the years 2008-2017. Six cases of invasive mucormycosis diagnosed during treatment for malignancies were included in the study. In 4 children (66%) mucormycosis occurred within the first 20 days after diagnosis of the underlying disease. Two cases were classified as proven mucormycosis and 4 as probable. The most frequently recorded species was Rhizopus arrhizus (2 patients), followed by Mucor spp (1), and Lichtheimia spp (1). All patients received liposomal amphotericin B. Combined antifungal treatment was used in 5 cases. Surgical excision was performed in 4 cases (66%). Two patients died at 6 and 12 months after the diagnosis, respectively, 1 (17%) because of mucormycosis. Our data suggest that mucormycosis may occur early after the initiation of intensive chemotherapy in children with malignancies.

Published
2021

10. Diagnostic Capacity for Invasive Fungal Infections in the Greek Paediatric Haematology-Oncology Units: Report from the Infection Working Group of the Hellenic Society of Paediatric Haematology-Oncology

Author

Markantonatou, Anthi-Marina, primary, Tragiannidis, Athanasios, additional, Galani, Vasiliki, additional, Doganis, Dimitrios, additional, Antoniadi, Kondilia, additional, Tsipou, Haroula, additional, Lambrou, Maria, additional, Katzilakis, Nikolaos, additional, Paisiou, Anna, additional, Palabougiouki, Maria, additional, Servitzoglou, Marina, additional, Papakonstantinou, Eugenia, additional, Peristeri, Ioulia, additional, Stiakaki, Efthichia, additional, Kosmidis, Eleni, additional, Polychronopoulou, Sophia, additional, Kattamis, Antonios, additional, and Vyzantiadis, Timoleon-Achilleas, additional

Published
2021
Full Text
View/download PDF

11. Survival and prognostic factors for childhood malignant liver tumors: analysis of harmonized clinical data

Author

Karalexi, Maria A., primary, Servitzoglou, Marina, additional, Moschovi, Maria, additional, Moiseenko, Roman, additional, Bouka, Panagiota, additional, Ntzani, Evangelia, additional, Kachanov, Denis, additional, Petridou, Eleni Th., additional, Antoniadi, Kondilia, additional, Baka, Margaret, additional, Dana, Helen, additional, Gavra, Maria, additional, Hatzipantelis, Emmanuel, additional, Kourti, Maria, additional, Malama, Astero, additional, Papaconstantinou, Evgenia, additional, Pelagiadis, Iordanis, additional, Polychronopoulou, Sofia, additional, Stefanaki, Kalliopi, additional, Steiakaki, Eftichia, additional, Strantzia, Katerina, additional, Akhaladze, Dmitry, additional, Filin, Andrey, additional, and Varfolomeeva, Svetlana, additional

Published
2021
Full Text
View/download PDF

12. Candidemia in Children with Malignancies: Report from the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology

Author

Vasileiou, Eleni, primary, Paisiou, Anna, additional, Tsipou, Charoula, additional, Pourtsidis, Apostolos, additional, Galani, Vasiliki, additional, Katzilakis, Nikolaos, additional, Antoniadi, Kondilia, additional, Papakonstantinou, Eugenia, additional, Ioannidou, Elda, additional, Stiakaki, Efthichia, additional, Baka, Margarita, additional, Kattamis, Antonios, additional, Kitra, Vasiliki, additional, and Tragiannidis, Athanasios, additional

Published
2020
Full Text
View/download PDF

14. Candidemia in Children with Malignancies: Report from the InfectionWorking Group of the Hellenic Society of Pediatric Hematology-Oncology.

Author

Vasileiou, Eleni, Paisiou, Anna, Tsipou, Charoula, Pourtsidis, Apostolos, Galani, Vasiliki, Katzilakis, Nikolaos, Antoniadi, Kondilia, Papakonstantinou, Eugenia, Ioannidou, Elda, Stiakaki, Efthichia, Baka, Margarita, Kattamis, Antonios, Kitra, Vasiliki, and Tragiannidis, Athanasios

Subjects
CANDIDEMIA, HEMATOLOGY, HOSPITAL care, ANTIBIOTICS, ONCOLOGY
Abstract

Candidemia is an important cause of morbidity and mortality especially in immunocompromised and hospitalized patients. We retrospectively collected data of candidemia cases that occurred in the seven Hematology-Oncology Departments/Units of Greece and the Stem Cell Transplant Unit between 2015 and 2019. In total, 19 episodes of candidemia in 19 patients were recorded. The majority of the patients (78.9%) had at least one risk factor for candidemia. The most frequent risk factors associated with candidemia observed in our patients were prolonged duration of hospitalization (30 days, range 1-141), presence of a central venous catheter at diagnosis of candidemia (73.7%) and antibiotics use during the last two weeks (84.2%). Candida parapsilosis was the most common species isolated accounting for 42.1%, followed by C. albicans (26.3%) and C. famata (15.8%). Nearly all of the patients (84.2%) received antifungal monotherapy with liposomal amphotericin B or echinocandins. The central venous catheter was removed in 78.6% of patients and the median time between the first positive blood culture and catheter removal was 3 days (range 1-9). Mortality at 28 days was 26.3%. In conclusion, a predominance of non-albicans species was observed in our study in conformity with the global trend. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

15. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology

Author

Antoniadi, Kondilia, Iosifidis, Elias, Vasileiou, Eleni, Tsipou, Charoula, Lialias, Ioannis, Papakonstantinou, Eugenia, Kattamis, Antonios, Polychronopoulou, Sophia, Roilides, Emmanuel, and Tragiannidis, Athanasios

Abstract

Mucormycosis is an invasive, life-threatening fungal infection that mainly affects immunocompromised hosts. We collected data of pediatric mucormycosis cases from all 7 Greek Hematology-Oncology Departments for the years 2008-2017. Six cases of invasive mucormycosis diagnosed during treatment for malignancies were included in the study. In 4 children (66%) mucormycosis occurred within the first 20 days after diagnosis of the underlying disease. Two cases were classified as proven mucormycosis and 4 as probable. The most frequently recorded species was Rhizopus arrhizus(2 patients), followed by Mucorspp (1), and Lichtheimiaspp (1). All patients received liposomal amphotericin B. Combined antifungal treatment was used in 5 cases. Surgical excision was performed in 4 cases (66%). Two patients died at 6 and 12 months after the diagnosis, respectively, 1 (17%) because of mucormycosis. Our data suggest that mucormycosis may occur early after the initiation of intensive chemotherapy in children with malignancies.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results